Generate BiomedicinesGENB

13F holders, Q1 2026 (March 31)
57holders
4famous investors
$12.47avg. 13F price*

At the end of Q1 2026, 57 institutions reported holding Generate Biomedicines Inc. (GENB) in their 13F filings. The largest holders were Flagship Pioneering, LLC ($783.4M), FMR LLC ($52.7M) and Capital World Investors ($50.1M). 4 famous investors held it, including Cathie Wood (0.0% of ARK Investment Management's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio).

Company
Generate Biomedicines Inc.
CUSIP
370920100
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080100 Q1 2026: 57Q1 2026Q2 2026: 86Q2 2026

Total Exit/New Position Q1 2026

InstitutionsTotal Value
New Positions54$1.2B
Exits0$0

Ownership 57 holders

Flagship Pioneering, LLC 67.44% New 62,673,117 $783.4M
FMR LLC 0.00% New 4,217,524 $52.7M
Capital World Investors 0.01% New 4,004,149 $50.1M
Braidwell LP 1.71% New 3,592,999 $44.9M
JPMorgan Chase & Co. 0.00% New 2,947,259 $33.9M
T. Rowe Price Associates Inc. 0.00% New 2,109,633 $26.4M
ARCH Venture Management, LLC 3.59% New 1,944,426 $24.3M
HarbourVest Partners LLC 21.33% New 1,722,210 $21.5M
Baker Bros. Advisors LP 0.10% New 1,423,602 $17.8M
Harvard Management Co. Inc. 0.77% New 1,111,100 $13.9M
Nvidia Corp. 0.06% New 833,325 $10.4M
Siren, L.L.C. 0.26% New 736,104 $9.2M
Davern Capital Partners, LP 2.03% New 591,800 $7.4M
Alyeska Investment Group, L.P. 0.02% New 500,000 $6.3M
ARK Investment Management 0.05% New 498,408 $6.2M
Millennium Management 0.00% New 376,893 $4.7M
UBS Group AG 0.00% New 356,704 $4.5M
Affinity Asset Advisors, LLC 0.26% New 350,000 $4.4M
Morgan Stanley 0.00% New 337,302 $4.2M
ExodusPoint Capital Management, LP 0.04% New 311,986 $3.9M
CenterBook Partners LP 0.18% New 266,813 $3.3M
Sphera Funds Management LTD. 0.40% New 185,000 $2.3M
Goldman Sachs Group Inc. 0.00% New 170,695 $2.1M
Vanguard Capital Management LLC 0.00% — 131,319 $1.6M
Seven Grand Managers, LLC 0.10% New 125,000 $1.6M
Jane Street Group, LLC 0.00% New 123,371 $1.5M
Geode Capital Management, LLC 0.00% New 118,243 $1.5M
Silverarc Capital Management, LLC 0.15% New 100,000 $1.3M
LMR Partners LLP 0.01% New 100,000 $1.3M
D. E. Shaw & Co. 0.00% New 95,000 $1.2M
Ameriprise Financial Inc. 0.00% New 87,335 $1.1M
Balyasny Asset Management L.P. 0.00% New 79,489 $994K
Manufacturers Life Insurance Company, The 0.00% New 74,312 $929K
Barclays PLC 0.00% New 70,894 $886K
HRT Financial LP 0.00% New 58,762 $734K
Qube Research & Technologies Ltd 0.00% New 50,221 $628K
TD Asset Management Inc 0.00% New 42,866 $536K
Sumitomo Mitsui Trust Group, Inc. 0.00% New 40,344 $504K
Amova Asset Management Americas, Inc. 0.01% New 40,344 $499K
Squarepoint Ops LLC 0.00% New 37,203 $465K
Bank of America Corp. 0.00% New 34,196 $427K
Federated Hermes, Inc. 0.00% New 30,000 $375K
Tudor Investment Corporation 0.00% New 23,833 $298K
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 0.02% New 19,203 $240K
Y-Intercept (Hong Kong) Ltd 0.00% New 18,362 $230K
Vanguard Fiduciary Trust Co. 0.00% — 17,456 $218K
Hudson Bay Capital Management LP 0.00% New 16,678 $208K
Diametric Capital, LP 0.03% New 10,497 $131K
Parallel Advisors, LLC 0.00% New 5,550 $69K
Albion Financial Group 0.00% New 4,854 $61K
FNY Investment Advisers, LLC 0.02% New 3,000 $37K
Citigroup Inc. 0.00% New 2,244 $28K
Vanguard Global Advisers, LLC 0.00% — 1,225 $15K
Wells Fargo & Company 0.00% New 1,200 $15K
Royal Bank of Canada 0.00% New 231 $3K
Avion Wealth 0.00% New 100 $1K
Tower Research Capital LLC (TRC) 0.00% New 1 $12

"% of holder's portfolio" is GENB's weight in each manager's 13F, not the share of Generate Biomedicines Inc. the manager owns.